MeSH tree: D12.776.543.750.695
Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as a therapy for both pain and opioid use disorder. In a study published in Nature, the team observed ...
Apr 1, 2026
0
20
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight ...
Mar 30, 2026
0
2
Scientists at City University of Hong Kong (CityUHK) have made progress in recent months with the discovery of a novel compound, named MF-8. The compound and its associated pharmaceuticals demonstrate significant potential ...
Mar 30, 2026
0
12
Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast cancer. Now, a new analysis ...
Mar 25, 2026
0
10
Whether they're using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health.
Mar 23, 2026
0
2
A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired Friday.
Mar 20, 2026
0
7
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...
Mar 18, 2026
0
21
Psilocybin is a naturally occurring psychedelic compound that is the active ingredient in certain types of mushrooms (also called magic mushrooms), long used by Indigenous communities in parts of Mexico and Central America ...
A new study in mice suggests psychedelics make the brain more likely to "see" images from memory rather than what's actually in front of it.
Mar 14, 2026
0
20
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing ...
Mar 13, 2026
0
16
